Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
aducanumab
advances in neurology
adverse drug reaction
agitation
Alzheimer's disease
Alzheimer's disease, age of onset
Alzheimer's disease, diagnosis of
Alzheimer's disease, early onset
Alzheimer's disease, early symptoms
Alzheimer's disease, familial
Alzheimer's disease, incidence
Alzheimer's disease, pathogenesis
Alzheimer's disease, preclinical
Alzheimer's disease, risk factors in
Alzheimer's disease, treatment of
Alzheimer's disease, vaccine
amnesia
amyloid
amyloid angiopathy, cerebral
amyloid angiopathy, cerebral, Boston criteria
amyloid angiopathy, cerebral, iatrogenic
amyloid angiopathy, cerebral, inflammatory type
amyloid beta protein
amyloid beta protein antibodies
amyloid beta-related angiitis
amyloid deposition
amyloid imaging
amyloid plaques
amyloidosis
amyloid-related imaging abnormalities
aneurysm, intracranial, familial
angiitis
angiitis, granulomatous of CNS
angiitis, isolated of CNS
angiography, cerebral
angiography, cerebral, false negative
angiography, cerebral, negative
anorectics
anti-amyloid therapy
anticholinesterase
anticoagulant, complications of
anticoagulant, contraindications
anticoagulant, discontinuation
anticoagulant, treatment
anticoagulant, treatment in CVD
anticonvulsants
aphasia
apolipoprotein E
APP
apraxia
apraxia, constructional
areflexia
asymptomatic
ataxia
ataxia, cerebellar
ataxia, hereditary
atrial fibrillation
behavioral disorder
biologic markers
blood pressure, control
blood transfusion
brain biopsy
CAT scan
CAT scan, abnormal
CAT scan, emission
CAT scan, emission, abnormal
CAT scan, false negative
central nervous system, infection of
cerebellar atrophy, primary
cerebellar atrophy, secondary
cerebellar degeneration
cerebellar plaques, amyloid
cerebral cortical atrophy
cerebral edema
cerebral edema, vasogenic
cerebrospinal fluid
cerebrospinal fluid, abnormal
cerebrospinal fluid, biochemical markers of CNS disease
cerebrospinal fluid, elevated protein of
cerebrospinal fluid, oligoclonal IgG in
cerebrospinal fluid, red cells in
cerebrospinal fluid, xanthochromia of
cerebrovascular accident
cerebrovascular accident, multiple
Clinical Pathologic Conference(C.P.C.)
cognition
coinfection
coma
complications
confusion
contraindications
controversies in neurology
cost
cost effectiveness
cryptococcal meningitis
cryptococcal meningoencephalitis
degenerative diseases of CNS
delusion
dementia
dementia, diagnostic evaluation of
dementia, early detection
dementia, familial
dementia, presenile
dementia, prevention of
dementia, rapidly progressive
dementia, reversible
dementia, screening for
dementia, transmissible
dementia, treatment of
depression
diagnostic criteria
differential diagnosis
disease modifying agents
disorientation
dizziness
donanemab
donepezil
dysarthria
dyskinesia
dyskinesia, buccal lingual facial
dyskinesia, drug induced
dysnomia
dyspraxia
echolalia
efficacy
electroencephalogram
electroencephalogram, abnormalities of
electromagnetic fields
encephalopathy
enzyme inhibition
epidemiology of neurology
executive dysfunction
facial weakness
false positive
familial
fatal familial insomnia
fenfluramine
fever
florbetapir
frontal lobe, anatomy and physiology
fungal infection
fungal infection, CNS
gadolinium
gait disorder
gene
gene mutation
genetic neurologic disorders
Gerstmann-Straussler-Scheinker disease
granulomatous disease
grasping
hallucination
hallucination, visual
head injury
headache
headache, severe
headache, sudden onset of
hematuria, microscopic
hemosiderosis of CNS, superficial
hemosiderosis, subarachnoid
hippocampal atrophy
hippocampus
histochemistry
histopathology
iatrogenic neurologic disorders
immunosuppression
immunosuppressive agents
immunotherapy
intellectual deterioration
intracerebral hemorrhage
intracerebral hemorrhage, lobar
intracerebral hemorrhage, location of
intracerebral hemorrhage, multiple
intracerebral hemorrhage, recurrent
intranasal medication
Jakob-Creutzfeldt disease
kuru
laughing, pathologic
lecanemab
leuko-araiosis
leukocytosis
level of consciousness, decreased
level of consciousness, fluctuating
memory, defect of recent
memory, evaluation of
memory, impairment of
memory, impairment of, subjective
memory, recent
meningeal biopsy
meningeal enhancement
meningoencephalitis
mental status, abnormal
microangiopathy, brain
microhemorrhage, intracerebral
microhemorrhage, intracerebral, location
mild cognitive impairment
mild cognitive impairment converting to Alzheimer's disease
mimics
Mini Mental Status Examination
misdiagnosis
mitochondrial disease
molecular genetics
mongolism
monoclonal antibodies
mortality
movement disorder
MRI
MRI, abnormal
MRI, contrast enhanced
MRI, disappearing lesion on
MRI, false negative
MRI, functional
MRI, gradient-echo
MRI, serial
MRI, sulcal hyperintensity
MRI, volumetry
multinucleated giant cell
myoclonic jerks
myoclonus
negative
neurofibrillary degeneration
neurologic complications of, surgery
neurologic disease
neurologic disease, diagnoses of
neurologic disease, multiple
neurologic examination, focal
neurologic testing
neuropathology
neuropathology, brain
neuroprotective agents
normal
old age, neurology of
opportunistic infection, CNS
paranoia
paraphasias
Parkinson disease
Parkinsonism syndrome
pathology
patient information and support
personality change
Pittsburgh Compound B
platelet inhibiting drugs
platelet inhibiting drugs, contraindications
pleocytosis of cerebrospinal fluid
preclinical
prevention of neurologic disorders
prion disease
prognosis
progressive neurologic disorder
psychological testing
psychosis
pursuit eye movements, abnormal
pyramidal tract dysfunction
rapidly progressing neurologic illness
recurrent
review article
risk factors
safety
screening
sedimentation rate, elevated
seizure
self-confidence
senile plaques
shared decision making
single photon emission computed tomography
small vessel disease
spongy degeneration of brain
startle myoclonus
statin therapy
statin therapy, discontinuation
steroid therapy, CNS treatment and complications with
subarachnoid hemorrhage
subarachnoid hemorrhage, cerebral convexity
tau protein
tauopathy
temporal lobe
tissue plasminogen activator, intravenous
TRAILBLAZER-ALZ trial
transient ischemic attack
transient neurologic deficit
treatment of neurologic disorder
vaccine
vasculitides
vasculopathy
Virchow-Robin spaces, dilated
virus, slow
visual loss
visuospatial disturbance
weight loss
white matter disease
white matter disease, subcortical
work performance
workup
Showing articles 850 to 900 of 1500 << Previous Next >>

Transmissible Spongiform Encephalopathies
NEJM 337:1821-1828, Haywood,A.M., 1997

Cerebral & Cerebellar Atrophy on Serial MRI in an Initially Symptom Free Subject at Risk of Familial Prion Disease
BMJ 315:856-857, Fox,N.C.,et al, 1997

CIDP:Clinical Features & Responses to Trtm in 67 Consecutive Pts with/without a Monoclonal Gammopathy
Neurol 48:321-328, Gorson,K.G.,et al, 1997

Cavernous Angioma of the Brain Stem Mimicking Multiple Sclerosis
NEJM 336:875-876, Vrethem,M.,et al, 1997

The 14-3-3 Brain Protein and Transmissible Spongiform Encephalopathy
NEJM 336:873-875, Moussavian,M.,et al, 1997

Seizures and Epilepsy in the Elderly
Arch Int Med 157:605-617, Thomas,R.J., 1997

Recurrent Intracerebral Hemorrhage
Neurol 49:106-113, Neau,J.P.,et al, 1997

Diagnosis of Cerebral Amyloid Angiopathy
G. , Stroke 28:1418-1422997., Greenberg,S.M.&Vonsattel,J-P, 1997

High Frequency of Apolipoprotein E e2 Allele in Hemorrhage Due to Cerebral Amyloid Angiopathy
Ann Neurol 41:716-721, 7011997., Nicoli,J.A.R.,et al, 1997

Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men
NEJM 336:973-979, 1014-10161997., Ridker,P.M.,et al, 1997

Character of MRI Response to Trtm with Interferon Beta-1B:Enhancing MRI Lesion Freq as Prim Outcome Measure
Neurol 49:862-869, Stone,L.A.,et al, 1997

Impact of Interferon Beta-1A On Neurologic Disability in Relapsing Multiple Sclerosis
Neurol 49:358-363, Rudick,R.A.,et al, 1997

Human Immunodeficiency Virus Infection and Stroke in Young Patients
Arch Neurol 54:1150-1153, Qureshi,A.I.,et al, 1997

A Comparison of Divalproex with Propranolol and Placebo for the Prophylaxis of Migraine Without Aura
Arch Neurol 54:1141-1145, Kaniecki,R.G., 1997

The Risk of Bovine Spongiform Encephalopathy ('Mad Cow Disease') to Human Health
JAMA 278:1008-1011, Brown,P., 1997

Detection of 14-3-3 Protein in the CSF of Genetic Creutzfeldt-Jakob Disease
Neurol 49:593-595, Rosemann,H.,et al, 1997

Epstein-Barr Virus Encephalomyelitis Diagnosed by Polymerase Chain Reaction:Detection of the Genome in the CSF
Neurol 48:1351-1355, Tselis,A.,et al, 1997

Lymphoproliferative Disorders and Motor Neuron Disease:An Update
Neurol 48:1671-1678, Gordon,P.H.,et al, 1997

Clinicopath Conf
Hodgkin's Disease, Paraneoplastic Cerebellar Degeneration, Case 21-1997, NEJM 337:115-12297., , 1997

New Variant Creutzfeldt-Jakob Disease:Neurological Features and Diagnostic Tests
Lancet 350:903-907, Zeidler,M.,et al, 1997

Granulomatous Angiitis of the Nervous System
In Vasculitis & The Nervous System, Neurol Clin 15:821-83497., Younger,D.S.,et al, 1997

Clinicopath Conf
Rocky Mountain Spotted Fever with Meningoencephalomyelitis, Vasculitis and Focal Myocarditis, Case 3, -17,NEJM 337:1149-1156,1997., 1997

Assessment of CSF Levels of Tau Protein in Mildly Demented Patients with Alzheimer's Disese
Neurol 48:632-635, Galasko,D.,et al, 1997

Mutations in the Sarcoglycan Genes in Patients with Myopathy
NEJM 336:618-624, Duggan,D.J.,et al, 1997

Drugs and Myasthenia Gravis, An Update
Arch Int Med 157:399-408, Wittbrodt,E.T., 1997

Correlation of Clinical, Magnetic Resonance Imaging, and Cerebrospinal Fluid Findings in Optic Neuritis
Ann Neurol 41:392-398, Jacobs,L.D.,et al, 1997

Syndrome of Orthostatic Headaches and Diffuse Pachymeningeal Gadolinium Enhancement
Mayo Clin Proc 72:400-413, Mokri,B.,et al, 1997

Adult-Onset Subacute Sclerosing Panecephalitis:Case Reports and Review of the Literature
Mov Dis 12:342-353, Singer,C.,et al, 1997

Amyloid Angiopathy-Related Cerebellar Hemorrhage
Surg Neurol 46:235-239, Cuny,E.,et al, 1996

A Controlled Study of Intravenous Immunoglobulin in Demyelinating Neuropathy with IgM Gammopathy
Ann Neurol 40:792-795, Dalakas,M.C.,et al, 1996

Intermittent Cyclophosphamide & Prednisone Trtm of Polyneuropathy Assoc with Monocl Gamopathy of Undeter Sign
Neurol 47:1227-1233, Notermans,N.C.,et al, 1996

Management of Patients Receiving Interferon Beta-1b for MS:Report of a Consensus Conf
Neurol 46:12-18, Lublin,F.D.,et al, 1996

Cerebral Venous Thrombosis:Role of Activated Protein C Resistance and Factor V Gene Mutation
Stroke 27:1719-1720, Brey,R.L.&Coull,B.M., 1996

Clinicopath Conf
Distinguishing Acute Disseminated Encephalomyelitis from Multiple Sclerosis, BMJ 313:802-8041996., , 1996

Neutralizing Antibodies During Treatment of Multiple Sclerosis with Interferon Beta-1b
IFNB MS Study Group & UBC MS. MRI Analysis Group, Neurol 47:889-8946., , 1996

Guidelines for Physicians with Patients on IFNB-1b:The Use of an Assay for Neutralizing Antibodies (NAB)
Neurol 47:865-866, Paty,D.,et al, 1996

Interferon Beta in Multiple Sclerosis
BMJ 313:1159, 1157, 1195996., Richards,R.G., 1996

The 14-3-3 Brain Protein in Cerebrospinal Fluid as a Marker for Transmissible Spongiform Encephalopathies
NEJM 335:924-930, 9631996., Hsich,G.,et al, 1996

Diagnosis of Creutzfeldt-Jakob Disease in Two-Dimensional Gel Electrophoresis of Cerebrospinal Fluid
Lancet 348:846-849, Zerr,I.,et al, 1996

Clinicopath Conf
Q Fever, Acute (with Cerebellar and Meningeal Involvement) , Case 38-1996, NEJM 335:1829-1834., , 1996

Creutzfeldt-Jakob Disease in a Young Woman
Lancet 347:945-948, Tabrizi,S.J.,et al, 1996

Diagnostic Criteria for Sporadic Creutzfeldt-Jakob Disease
Arch Neurol 53:913-920, Kretzschmar,H.A.,et al, 1996

MR Findings in Listerial Rhombencephalitis
AJNR 17:593-596, Alper,G.,et al, 1996

Lyme Radiculoneuritis Treated with Intravenous Immunoglobin
Neurol 46:1174-1175, Crisp,D.&Ashby,P., 1996

Inclusion Body Myositis
JNNP 60:251-255, Garlepp,M.J.&Mastaglia,F.L., 1996

Niemann-Pick Disease Type C from Bench to Bedside
JAMA 276:561-564, Schiffmann,R., 1996

Leptomeningeal Carcinomatosis:Presenting Features and Prognostic Factors
Arch Neurol 53:626-632, Balm,M.&Hammack,J., 1996

Recovery from Coma Caused by Primary CNS Mantle Cell Lymphoma Presenting as Encephalitis
Neurol 46:824-826, Finsterer,J.,et al, 1996

Side Effect Profile of Interferon Beta-1b in MS:Results of an Open Label Trial
Neurol 46:552-554, Neilley,L.K.,et al, 1996

Cerebrospinal Fluid in Acute Optic Neuritis:Experience of the Optic Neuritis Treatment Trial
Neurol 46:368-372, Rolak,L.A.,et al, 1996



Showing articles 850 to 900 of 1500 << Previous Next >>